We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Researchers Urge FDA to Quickly Withdraw Accelerated Approvals After Negative Trial Data
Researchers Urge FDA to Quickly Withdraw Accelerated Approvals After Negative Trial Data
The FDA should move more quickly to withdraw its approval of drugs granted Accelerated Approval (AA) when negative confirmatory trial data emerge, said members of a research team that studied cancer patients treated with AA drugs.